$67.29
1.84% day before yesterday
NYSE, Apr 17, 10:16 pm CET
ISIN
US1266501006
Symbol
CVS

CVS Health Stock price

$67.29
+0.64 0.96% 1M
+3.62 5.69% 6M
+22.40 49.90% YTD
-1.31 1.91% 1Y
-36.13 34.94% 3Y
+3.93 6.20% 5Y
-33.10 32.97% 10Y
NYSE, Closing price Thu, Apr 17 2025
-1.26 1.84%
ISIN
US1266501006
Symbol
CVS
Industry

Key metrics

Market capitalization $84.95b
Enterprise Value $156.95b
P/E (TTM) P/E ratio 18.40
EV/FCF (TTM) EV/FCF 24.81
EV/Sales (TTM) EV/Sales 0.42
P/S ratio (TTM) P/S ratio 0.23
P/B ratio (TTM) P/B ratio 1.12
Dividend yield 3.95%
Last dividend (FY24) $2.66
Revenue growth (TTM) Revenue growth 4.02%
Revenue (TTM) Revenue $372.69b
EBIT (operating result TTM) EBIT $9.92b
Free Cash Flow (TTM) Free Cash Flow $6.33b
Cash position $11.09b
EPS (TTM) EPS $3.66
P/E forward 11.33
P/S forward 0.22
EV/Sales forward 0.40
Short interest 1.46%
Show more

Is CVS Health a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,780 stocks worldwide.

CVS Health Stock Analysis

Unlock Scores for Free

Analyst Opinions

30 Analysts have issued a CVS Health forecast:

19x Buy
63%
11x Hold
37%

Analyst Opinions

30 Analysts have issued a CVS Health forecast:

Buy
63%
Hold
37%

Financial data from CVS Health

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
372,692 372,692
4% 4%
100%
- Direct Costs 321,408 321,408
6% 6%
86%
51,284 51,284
7% 7%
14%
- Selling and Administrative Expenses 36,766 36,766
5% 5%
10%
- Research and Development Expense - -
-
-
14,518 14,518
27% 27%
4%
- Depreciation and Amortization 4,597 4,597
5% 5%
1%
EBIT (Operating Income) EBIT 9,921 9,921
36% 36%
3%
Net Profit 4,614 4,614
45% 45%
1%

In millions USD.

Don't miss a Thing! We will send you all news about CVS Health directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

CVS Health Stock News

Positive
Seeking Alpha
one day ago
March investments totaled around $1,200, mainly in BDCs like Blue Owl Capital and Ares Capital, boosting annual dividend income by $100. Dividend income hit a new all-time record of $1,404, up 17% Y/Y driven by substantial purchases over the last twelve months. Focus remains firmly on maintaining rising BDC dividends and achieving a monthly increase of at least $100 in dividend income.
Positive
CNBC
3 days ago
CNBC's Jim Cramer on Tuesday suggested why CVS and Dollar General have seen gains recently after lagging last year. He attributed the turnaround in part to the idea that these two have become the most competitive in their respective sectors.
Neutral
MarketBeat
4 days ago
The medical sector stocks, notably the health insurance carriers, took a major drubbing in 2024 as Medicare Advantage (MA) plans continued to drive higher utilization costs, eating away at profits. These rising costs are illustrated by the medical benefits ratio (MBR), benefits expense ratio (BER), medical care ratio (MCR) or medical loss ratio (MLR), which is the percentage of premiums used to...
More CVS Health News

Company Profile

CVS Health Corp. engages in the provision of health care services. It operates through the following segments: Pharmacy Services, Retail or Long Term Care, Health Care Benefits, and Corporate. The Pharmacy Services segment offers pharmacy benefit management solutions. The Retail or Long Term Care segment includes selling of prescription drugs and assortment of general merchandise. The Health Care Benefits segment offers traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioural health, medical management capabilities. The Corporate segment involves in providing management and administrative services. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

Head office United States
CEO J. Joyner
Employees 300,000
Founded 1963
Website www.cvshealth.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today